← Research library

Effects of Livagen peptide on chromatin activation in lymphocytes from old people.

Lab research · 2002

What was studied
Cultured lymphocytes from older donors
Main finding
Livagen altered chromatin organization and ribosomal-gene activity in donor-derived lymphocytes.

Study data at a glance

Participants or experimental model
Cultured lymphocytes from older donors
Reported results
Livagen altered chromatin organization and ribosomal-gene activity in donor-derived lymphocytes.
Study limitations and source details

Study limitations

  • Cells from human donors are not a human treatment trial; rejuvenation and liver benefit were not established.
  • Full methods, reporting completeness and independent replication remain to be appraised.

Source details

Original journal report

Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.

Abstract reviewed

Sources checked

Citation

Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology

In vitroEnglish abstract

Khavinson VKh, Lezhava TA, Monaselidze JG, Dzhokhadze TA, Dvalishvili NA, Bablishvili NK, Ryadnova IY. Effects of Livagen peptide on chromatin activation in lymphocytes from old people. Bulletin of experimental biology and medicine · PMID 12533768

Study source ↗ · DOI 10.1023/a:1021924702103 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards